Copy
View this email in your browser
Keep abreast of the latest developments and technologies in the area of PGD/PGT with the experts in the field. 

Seats are filling fast for the HALF Masterclass. Do not miss this learning opportunity!

HALF Masterclass: 12 - 13 October 2017
Venue: Excemon Beijing Hongxiang Hotel
Registration Fee per pax: USD 450.00


Registration closes on 11 September 2017.
Invitation letters can be arranged upon request.


SEATS FOR FULL MASTERCLASS ARE FULLY BOOKED.
Download Registration Form
Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD) are increasing requested by couples who are undergoing infertility treatments. Knowledge of PGS and PGD is therefore integral to contemporary fertility care. 
KNOW OUR SPEAKERS
Professor Jie Qiao
President, Peking University Third Hospital (PUTH), Beijing, China
Prof Jie Qiao has been focusing on the basic research of reproductive development, mechanism of infertility, and improvement of new techniques in infertility diagnosis and management. She built a research team combined with basic and clinical medicine, and established a series of prominent clinical research database. Her research reveals critical mechanisms of infertility and developmental regulation. 
Dr Rong Li
Deputy Director, Reproductive Medical Center and Department of Obstetrics and Gynecology
Peking University Third Hospital (PUTH), Beijing, China
Dr Li specializes in clinical treatment, education and medical researches within the fields of Obstetrics and Gynecology with research directions on reproductive medicine, female fertility evaluation, endometrial receptivity and PCOS. She published more than 60 SCI articles in medical journals, including Cell, Nature, Lancet, et al. Her researches had been funded through variety of grants, such as National "Twelfth Five-Year" Plan for Science & Technology Support.
Dr Clare Boothroyd
IVFMed, Greenslopes Specialist Centre, Queensland, Australia
Dr Boothroyd is the only specialist in Queensland with full qualifications in both specialties of endocrinology and gynaecology. She established an independently owned IVF unit in 2008, Care Fertility of which she is Medical Director and oversaw the introduction of PGT to the unit in 2016.
Dr Wong Pak Seng
Sunfert International, Malaysia
After becoming a Member of the Royal College of Obstetricians & Gynaecologists (RCOG), United Kingdom (UK) in 2000, he pursued a Fellowship in Infertility and Reproductive Medicine at the London Fertility Centre under the tutelage of Prof Ian Craft.  He founded Sunfert International in 2009 from ground-up. Sunfert International is currently a leading fertility group in Malaysia. His current interest is in embryo selection using both morphokinetic markers and pre-implantation genetics. 
Dr Alpesh Doshi
Consultant Embryologist, Embryology and PGD Academy
Dr Doshi is one of the co-founder of The Embryology and PGD Academy. He joined The Centre of Reproductive and Genetic Health (formerly the Assisted Conception Unit at UCLH) in 1999, a clinic that has consistently achieved one of the highest live birth rates in the UK. He is currently the Head of Embryology and also an honorary consultant at the UCLH NHS trust. In 2004 he became recognised by the Health professions Council as a state registered clinical embryologist and in 2008 he was in the first group to qualify with ESHRE as a European Senior Clinical Embryologist. 
Dr Alan Thornhill
Igenomix, United Kingdom
Following his post-doctoral work in single cell genetics at the Institute of Child Health, London, Dr Thornhill trained as a clinical embryologist at Kings College and St Thomas' Hospital before directing IVF laboratories in the USA (Mayo Clinic, Rochester, Minnesota) and UK (Guy’s Hospital, The Bridge Centre and London Fertility Centre) specialising in Preimplantation Genetics. Alan's research interests include reproductive genetics, PGD and improving the safety and effectiveness of IVF. 
Dr George Liperis
Westmead Fertility Centre, University of Sydney, Australia
Dr Liperis is an ESHRE certified Clinical and Research Embryologist with a background in Assisted Reproduction and Reproductive sciences, practicing Clinical Embryology, combining genetic analysis and research in Human reproduction. Over the last year, he has balanced the role of Clinical Genetic technologist at VIAFET genomics center, involved in the genetic analysis for patients undergoing PGT. His list of publications includes book chapters in routine quality control and control of variables in the IVF laboratory.
Dr Hiroki Kurahashi
Department of Molecular Genetics, Fujita Health University, Japan
Dr. Kurahashi started research activity for molecular cytogenetics in 1991. His main interest is a mechanism for chromosomal abnormalities. He is currently working as a researcher in the Department of Molecular Genetics, ICMS, Fujita Health University, as well as a medical geneticist in the Department of Genetic Counseling in the Fujita Health University Hospital. He is a board member of Japanese Society of Human Genetics and an Associate Editor of Journal of Human Genetics.
Dr Jan Liebelt
SA Pathology
Dr Liebelt completed undergraduate training at the University of Adelaide, with postgraduate studies in paediatrics and clinical genetics at the Women's and Children's Hospital and Royal Children’s Hospitals in Brisbane and Melbourne. She undertook further training via the Fetal Medicine Foundation Kings College, London, to assist in her primary interest of prenatal genetics. Her main areas of clinical and research interest include reproductive genetics (in association with the Repromed IVF unit in Adelaide), prenatal genetics and dysmorphology.
Dr Eileen Tan
Illumina Inc, Singapore
Dr Tan is the Asia-Pacific Market Development Manager for Illumina Inc. Her focus is in the area of Preconception and Fertility. Prior to this role, she was the Team Leader for the regional applications scientist team in Life Technologies Holdings and then Thermo Fisher Scientific, providing training and support on the applications of Next Generation Sequencing technologies in different market segments including Reproductive and Genetic Health. From her many years in the industry, she has built a strong technical expertise and knowledge around next generation sequencing technologies.
Dr Jin Huang
Peking University 3rd Hospital
Dr Huang works in the reproductive center of Peking University 3rd Hospital. From 2004, she focused on PGD/PGS field, from FISH to array and NGS. She can do both embryo biopsy and genetic diagnosis. She published more than 10 papers about PGD/PGS on the international jounals, such as Fertility and Sterility, Prenatal Disgnosis and so on. She got the second award of the National Scientific and Technological Progress in 2011 and the first award of outstanding achievements in scientific research by the Ministry of education in 2014. 

Assoc Prof Yang Yu
Peking University 3rd Hospital
Assoc Prof Yu is the Principal Investigator in the ART Engineering Group and the Vice Director of Beijing Key Laboratory of Reproductive Endocrinology and Assisted Reproductive Technology. Assoc Prof Yu is also the Academic editor for PLoS ONE Journal and members of International Society for Stem Cell Research (ISSCR) and American Society of Reproductive Medicine (ASRM).

Dr Yan Junhao
Director of Department of Reproductive Genetics, Center for Reproductive Medicine, Shandong University
Dr Yan is the Director of the Center for Reproductive Medicine, Shandong University which has been approved as the only institution allowed for PGD/PGS in Shandong province. In January 2015, he took part as a main clinical operator in the birth of a heathy baby after PGD treatment for a couple of deafness gene carriers, which was the first case in China. 

Prof Yanwen Xu
Director of the reproductive medical center of the First Affiliated Hospital of Sun Yat-sen University
Dr Xu works at the reproductive medical center of the First Affiliated Hospital of Sun Yat-sen University. She got the first successful PGD live birth in China 1999. Her main research interests are preimplantation genetic diagnosis, mechanism of aneuploidy, and miRNA regulation in human oocytes and embryos. Currently, she is the vice chairman of Society of Reproductive Medicine in Guangdong Province, vice chairman of the Youth Committee of Chinese Society of Reproductive Medicine.

Dr Liu Ping
Deputy Director, Peking University 3rd Hospital
Dr Liu, a Chief Physician in Obstetrics and Gynecology, is one of the leading experts on reproductive endocrinology, female infertility and ART. She is among the pioneers who established the IVF technology in China. With the efforts of Dr. Liu and her supervisor, Prof. Lizhu Zhang, the first IVF-ET baby in China was born in Peking University Third Hospital in 1984. Dr. Liu is also one of the key investigators for the accomplishment of the first fallopian tube embryo transfer, the first frozen-thawed embryo transfer, and the first donor egg/sperm IVF in China. She has been engaged in studying and performing the up-to-date ART in clinical work for almost three decades and has obtained the state scientific and technological progress award, and other technological progress awards by the ministry of health, the ministry of education and the Beijing Municipal Commission.      
MASTERCLASS PROGRAMME
EXPLORE BEIJING
One of the World's Great Ancient Capitals
Take this opportunity to explore Beijing,
the capital of the People's Republic of China and one of the World's Great Ancient Capitals.
Asia Pacific Initiative on Reproduction

1 Fusionopolis Place, Galaxis (West Lobby) #03-20, Singapore 138522
Tel: +65 6809 1181 | Email: jqhoa@aspire-reproduction.org
Website: www.aspire-reproduction.org






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Asia Pacific Initiative on Reproduction · 1 Fusionopolis Place · Galaxis (West Lobby), #03-20 · Singapore 138522 · Singapore

Email Marketing Powered by Mailchimp